欧洲败血症诊断市场 – 行业趋势和 2029 年预测

欧洲败血症诊断市场分析与洞察

败血症是一种可能危及生命的疾病，当身体对感染的反应损害了自身组织时就会发生。当抗感染过程对身体起作用时，它们会导致器官功能不良和异常。败血症可能发展为感染性休克。这是一种血压急剧下降，可能导致严重的器官问题和死亡。要诊断败血症，必须通过精神状态、收缩压、呼吸频率等体征来确认感染。大多数情况下，败血症发生在住院患者或最近住院的患者身上。重症监护病房的患者更容易感染，然后导致败血症。为了诊断败血症，除了血液检查外，还需要进行其他实验室检查。血液样本用于检测感染、凝血问题、肝肾功能异常、氧气供应受损、电解质失衡的证据。败血症患者需要在医院重症监护病房接受密切监测和治疗。可能需要采取救生措施来稳定呼吸和心脏功能。

欧洲败血症诊断市场预计将在 2022 年至 2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2022 年至 2029 年的预测期内，该市场将以 6.9% 的复合年增长率增长，预计将从 2021 年的 2.4949 亿美元达到 2029 年的 4.5618 亿美元。

Sepsis Diagnostics Market Dynamics

Drivers

• Rising incidence of hospital-acquired infections

With the rapid increase in HAIs worldwide, there is an increase in the demand for proper sepsis diagnostic products will increase in upcoming years. Therefore, rising incidences of hospital-acquired infections are expected to act as a driver for the growth of the sepsis diagnostics market.

• Rising healthcare expenditure

Another significant factor influencing the growth rate of sepsis diagnostics market is the rising healthcare expenditure which helps in improving its infrastructure.

• Growing prevalence of sepsis

Growing prevalence of sepsis in various regions worldwide and various infections associated with it are expected to act as drivers for the growth of the sepsis diagnostics market

Furthermore, advancement in medical technology, rising initiatives by public and private organizations to spread awareness and growing government funding are the factors that will expand the sepsis diagnostics market.  

Opportunities

• Evolution of novel biomarkers for sepsis diagnosis

Sepsis is one of the leading causes of mortality and morbidity, even with the current availability of extended-spectrum antibiotics and advanced medical care. Biomarkers offer a tool in facilitating early diagnosis, in identifying patient populations at high risk of complications, and in monitoring the progression of the disease, which are critical assessments for appropriate therapy and improvement in patient outcomes.

Also, the launch of effective therapies and continuous clinical trials will provide beneficial opportunities for the sepsis diagnostics market in the forecast period of 2022-2029. Also, high unmet need of current treatment and developments in healthcare technology will escalate the growth rate sepsis diagnostics market in future.

Restraints/Challenges

However, high cost of diagnosis and lack of appropriate testing for sepsis will impede the growth rate of sepsis diagnostics market. Additionally, lack of awareness about sepsis will further challenge the market in the forecast period mentioned above.

This sepsis diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on sepsis diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post COVID-19 Impact on Sepsis Diagnostics Market

The COVID-19 has negatively affected the market. Lockdowns and isolation during pandemics complicate the disease management and medication adherence. The lack of access to health-care facilities for routine treatment and medication administration will further affect the market. Social isolation increases stress, despair, and social support, all of which may cause a reduction in sepsis medication adherence during the pandemic.

Recent Development

• In July 2021, DiaSorin S.p.A announced that they acquired Luminex Corporation which develops, manufactures, and markets biological testing technologies in the clinical diagnostic and life science industries. This acquisition will help company gain technological advancements for its current product portfolio thereby expected in improving its position in market.

Europe Sepsis Diagnostics Market Scope

The Europe sepsis diagnostics market is segmented into techniques and test type. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Techniques

• Immunoassay
• Molecular Diagnostic
• Microbiology
• Flow Cytometry

On the basis of techniques, the Europe sepsis diagnostics market is segmented into microbiology, molecular diagnostic, immunoassay, and flow cytometry. The segment of immunoassay is further sub-segmented into Procalcitonin (PCT), Interleukin-6 (IL-6), C-Reactive Protein (CRP), Pentraxin-3 (PTX3), Calprotectin and Others.   

Test Type

• Laboratory Testing
• Point of Care Testing

On the basis of test type, the Europe sepsis diagnostics market is segmented into laboratory testing and point of care testing.

Sepsis Diagnostics Market Regional Analysis/Insights

The sepsis diagnostics market is analysed and market size insights and trends are provided by country, techniques and test type as referenced above.

The countries covered in the Europe sepsis diagnostics market report are Germany, U.K., France and Rest of Europe.

Germany dominates the Europe sepsis diagnostics market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the fact that residents in lower socioeconomic status along with lower proximity of medical services in Germany are associated with their increased sepsis incidence. The rising number of market players and their manufacturing facilities in the country is further enhancing the market growth.

报告的国家部分还提供了影响单个市场因素和市场法规变化的信息，这些因素和变化会影响市场的当前和未来趋势。新旧销售、国家人口统计、疾病流行病学和进出口关税等数据点是预测单个国家市场情况的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因本土和国内品牌的激烈竞争而面临的挑战以及销售渠道的影响。

竞争格局和败血症诊断市场份额分析

败血症诊断 市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对败血症诊断 市场的关注有关。

败血症诊断市场的一些主要参与者 包括 Trinity Biotech（爱尔兰）、Meridian Bioscience、Omega Diagnostics Group PLC.、Xcyton Diagnostics Limited、Diasorin SpA、Seegene Inc.、EKF Diagnostics Holdings plc.、Axis-Shield Diagnostics Ltd.、Immunexpress Inc.、Luminex Corporation、bioMérieux SA、BD、Thermo Fisher Scientific Inc. Abbott、Roche Diagnostics、Cepheid、Beckman Coulter, Inc.、T2 Biosystems, Inc. 和 Bruker Ortho Clinical Diagnostics 等。

研究方法：欧洲败血症诊断市场

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域以及供应商份额分析。如有进一步询问，请要求分析师致电。

SKU-67936